腾盛博药-B授出60万份购股权

Core Viewpoint - The company Tengsheng Bo Pharmaceutical-B (02137) announced the granting of 600,000 stock options under its 2023 stock option plan, pending acceptance by the grantees [1] Group 1 - As of the announcement date, the total number of issued shares is 720.9 million (excluding treasury shares) [1] - The stock options, if fully exercised, will represent approximately 0.08% of the total issued shares as of the announcement date (excluding treasury shares) [1] - The expanded total issued shares, after the exercise of the stock options, will also represent about 0.08% (excluding treasury shares) [1]